2BMC | date | ![]() |
|||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
authors | |||||||||||||||
compound | source | ||||||||||||||
symmetry |
| ||||||||||||||
crystal cell |
| ||||||||||||||
method | X-Ray Diffraction | resolution | |||||||||||||
ligand | MPY | enzyme |
| ||||||||||||
related structures | by homologous chain: 1OL5, 1OL7 | ||||||||||||||
Gene Ontology ![]() |
| ||||||||||||||
Primary reference | Potent and selective Aurora inhibitors identified by the expansion of a novel scaffold for protein kinase inhibition., Fancelli D, Berta D, Bindi S, Cameron A, Cappella P, Carpinelli P, Catana C, Forte B, Giordano P, Giorgini ML, Mantegani S, Marsiglio A, Meroni M, Moll J, Pittala V, Roletto F, Severino D, Soncini C, Storici P, Tonani R, Varasi M, Vulpetti A, Vianello P, J Med Chem. 2005 Apr 21;48(8):3080-4. PMID:15828847 |
Data retrieval |
![]() |
View 2BMC in 3D |
![]() |
Structure-derived information |
Sequence-derived information |
OCA© by Jaime Prilusky, 1996-2014,2022,2024 Bioinformatics Unit Weizmann Institute of Science |